Pharmacodynamic Models for Discrete DataPAULE, Ines; GIRARD, Pascal; FREYER, Gilles et al.Clinical pharmacokinetics. 2012, Vol 51, Num 12, pp 767-786, issn 0312-5963, 20 p.Article

Pharmacodynamic Effects in the Cardiovascular System: The Modeller's ViewFINK, Martin; NOBLE, Denis.Basic & clinical pharmacology & toxicology (Print). 2010, Vol 106, Num 3, pp 243-249, issn 1742-7835, 7 p.Conference Paper

Pharmacodynamic Effects of Haematopoietic Cytokines: The View of a Clinical OncologistHELD, Thomas K; GUNDERT-REMY, Ursula.Basic & clinical pharmacology & toxicology (Print). 2010, Vol 106, Num 3, pp 210-214, issn 1742-7835, 5 p.Conference Paper

Reporting a Population Pharmacokinetic-Pharmacodynamic Study: A Journal's PerspectiveJAMSEN, Kris M; McLEAY, Sarah C; BARRAS, Michael A et al.Clinical pharmacokinetics. 2014, Vol 53, Num 2, pp 111-122, issn 0312-5963, 12 p.Article

Pharmacokinetic and pharmacodynamic properties important for inhaled corticosteroidsHOCHHAUS, Gunther.Annals of allergy, asthma, & immunology. 2007, Vol 98, Num 2, issn 1081-1206, S7-S15, SUP2Article

Genesis of clinical pharmacokinetic/pharmacodynamic concepts : E.K. Marshall, Jr.'s roleLEVY, G.The Annals of pharmacotherapy. 1994, Vol 28, Num 11, pp 1300-1302, issn 1060-0280Article

Pharmacokinetic-pharmacodynamic modelling : History and perspectivesCSAJKA, Chantal; VEROTTA, Davide.Journal of pharmacokinetics and pharmacodynamics (Print). 2006, Vol 33, Num 3, pp 227-279, issn 1567-567X, 53 p.Article

Stereoselective drug disposition: potential for misinterpretation of drug disposition dataEVANS, A. M; NATION, R. L; SANSOM, L. N et al.British journal of clinical pharmacology. 1988, Vol 26, Num 6, pp 771-780, issn 0306-5251Article

Pharmacokinetic/Pharmacodynamic Modelling in Diabetes MellitusLANDERSDORFER, Cornelia B; JUSKO, William J.Clinical pharmacokinetics. 2008, Vol 47, Num 7, pp 417-448, issn 0312-5963, 32 p.Article

Role of Microdialysis in Pharmacokinetics and Pharmacodynamics: Current Status and Future DirectionsAZEREDO, Francine Johansson; COSTA, Teresa Dalla; DERENDORF, Hartmut et al.Clinical pharmacokinetics. 2014, Vol 53, Num 3, pp 205-212, issn 0312-5963, 8 p.Article

ETUDE DE CERTAINS ESTERS DE LA RACINE DE CENTRANTHUS RUBER ET ACTION PHARMACODYNAMIQUE DE QUELQUES-UNES DE SES PREPARATIONS GALENIQUESADZET T; IGLESIAS J; SAN MARTIN R et al.1975; PLANTA MED.; ALLEM.; DA. 1975; VOL. 27; NO 2; PP. 194-198; ABS. ANGL.; BIBL. 14REF.Article

On the prediction of the human response : A recycled mechanistic pharmacokinetic/pharmacodynamic approachMENO-TETANG, Guy M. L; LOWE, Philip J.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 182-192, issn 1742-7835, 11 p.Article

PHARMACODYNAMICS AND MARKERS OF DRUG EFFECTSGALEAZZI RL.1980; THER. DRUG MONIT.; USA; DA. 1980; VOL. 2; NO 1; PP. 11-17; BIBL. 23 REF.Article

INCONTRI ITALO-FRANCESI DI NEURORADIOLOGIA. I. TAVOLA ROTONDA. FARMACODINAMICA E QUADRI RADIOLOGICI DELLA VASOMOTILITA CEREBRALE. CAPRI; 1973 = RENCONTRES FRANCO-ITALIENNES DE NEURORADIOLOGIE. I. TABLE RONDE. PHARMACODYNAMIE ET TABLEAUX ANGIOGRAPHIQUES DE LA VASOMOTRICITE CEREBRALE. CAPRI; 19731974; ACTA NEUROL.; ITAL.; DA. 1974; VOL. 29; NO 2; PP. 105-226; BIBL. DISSEM.Conference Paper

Pharmacokinetic/pharmacodynamic modelling in oncological drug developmentKARLSSON, Mats O; ANEHALL, Therese; FRIBERG, Lena E et al.Basic & clinical pharmacology & toxicology (Print). 2005, Vol 96, Num 3, pp 206-211, issn 1742-7835, 6 p.Article

GENETIC INFLUENCES ON PHARMACODYNAMIC PROPERTIES OF PSYCHOTROPIC DRUGSPROPPING P; FRIEDL W.1979; PHARMACOLOGY; CHE; DA. 1979; VOL. 19; NO 1; PP. 1-4; BIBL. 23 REF.Article

Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating AgentsDOSHI, Sameer; KRZYZANSKI, Wojciech; YUE, Susan et al.Clinical pharmacokinetics. 2013, Vol 52, Num 12, pp 1063-1083, issn 0312-5963, 21 p.Article

Development ofTranslational Pharmacokinetic-Pharmacodynamic ModelsMAGER, D. E; JUSKO, W. J.Clinical pharmacology and therapeutics. 2008, Vol 83, Num 6, pp 909-912, issn 0009-9236, 4 p.Article

Disease Severity Is a Major Determinant for the Pharmacodynamics of Propofol in Critically III PatientsPEETERS, M. Y. M; BRAS, L. J; DEJONGH, J et al.Clinical pharmacology and therapeutics. 2008, Vol 83, Num 3, pp 443-451, issn 0009-9236, 9 p.Article

Pharmacodynamics and Pharmacokinetics of the Novel Thrombopoietin Mimetic Peptide RWJ-800088 in HumansLIEM-MOOLENAAR, M; CERNEUS, D; MOLLOY, C. J et al.Clinical pharmacology and therapeutics. 2008, Vol 84, Num 4, pp 481-487, issn 0009-9236, 7 p.Article

Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administrationKELLER, Alexandra; ZIDA WU; KRATZSCH, Juergen et al.European journal of endocrinology. 2007, Vol 156, Num 6, pp 647-653, issn 0804-4643, 7 p.Article

Pharmacodynamic Markers of Perifosine EfficacyHENNESSY, Bryan T; YILING LU; HENDERSON, I. Craig et al.Clinical cancer research. 2007, Vol 13, Num 24, pp 7421-7431, issn 1078-0432, 11 p.Article

AntibioticsOrtega Morente, Elena; Espinosa Ubeda, Antonio.2005, isbn 81-7736-291-7, 1Vol, 232 p., isbn 81-7736-291-7Book

Estimating the maximum effective dose in a quantitative dose-response experimentREMMENGA, M. D; MILLIKEN, G. A; KRATZER, D et al.Journal of animal science. 1997, Vol 75, Num 8, pp 2174-2183, issn 0021-8812Article

Pharmacodynamic Variability beyond That Explained by MICsSOON, Rachel L; LY, Neang S; GAURI RAO et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 4, pp 1730-1735, issn 0066-4804, 6 p.Article